i²medi is now commercializing the cardiological products under the brand i²cardio. Our clients and our partners companies can rely on excellence in service and professional sales support. Competent interfaces, broad sales presence, and trustful sales management remains unchanged and follows the i²medi principles: attain, gain and sustain.

Our products span early detection, advanced diagnostics and unique therapy:

• From early detection of CAD, or structural heart disease via cardisiography (Cardisio)
• New Hope for severe refractory heart failure patients: Cardiac contractility Modulation (Impulse Dynamics)
• Unique therapy guidance to treat heart failure and myocarditis based upon endomyocardial biopsies (IKDT)